metformin and rociletinib

metformin has been researched along with rociletinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, HY; He, Y; Li, L; Lin, CY; Lu, CH; Pan, YH; Wang, YB	1

Other Studies

1 other study(ies) available for metformin and rociletinib

Article	Year
Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling. The clinical respiratory journal, 2018, Volume: 12, Issue:12 Topics: Acrylamides; Apoptosis; Cell Line, Tumor; Cell Proliferation; China; Drug Resistance; Drug Synergism; ErbB Receptors; Humans; Hypoglycemic Agents; Lung Neoplasms; Metformin; NF-kappa B; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction	2018

Article

Year

Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling.

The clinical respiratory journal, 2018, Volume: 12, Issue:12

Topics: Acrylamides; Apoptosis; Cell Line, Tumor; Cell Proliferation; China; Drug Resistance; Drug Synergism; ErbB Receptors; Humans; Hypoglycemic Agents; Lung Neoplasms; Metformin; NF-kappa B; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction

2018